<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Antimicrobial recommendations for acute biliary infections</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Antimicrobial recommendations for acute biliary infections</h1>
<div class="graphic"><div class="figure"><div class="ttl">Antimicrobial recommendations for acute biliary infections</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1" rowspan="2">Severity</td> <td class="subtitle1" colspan="3">Community-acquired biliary infections</td> <td class="subtitle1" rowspan="2">Health-care-associated biliary infections*</td> </tr> <tr class="divider_bottom"> <td class="subtitle2">Grade I</td> <td class="subtitle2">Grade II</td> <td class="subtitle2">Grade III*</td> </tr> <tr class="divider_bottom"> <td class="subtitle3">Antimicrobial agents</td> <td class="subtitle3">Cholangitis and cholecystitis</td> <td class="subtitle3">Cholangitis and cholecystitis</td> <td class="subtitle3">Cholangitis and cholecystitis</td> <td class="subtitle3">Health-care-associated cholangitis and cholecystitis</td> </tr> <tr class="divider_bottom"> <td>Penicillin-based therapy</td> <td>Ampicillin/sulbactam<sup>¶</sup> is not recommended if &gt;20% resistance rate</td> <td>Piperacillin/tazobactam</td> <td>Piperacillin/tazobactam</td> <td>Piperacillin/tazobactam</td> </tr> <tr class="divider_bottom"> <td rowspan="2">Cephalosporin-based therapy</td> <td> <p>Cefazolin,<sup>Δ</sup></p> <p>or cefotiam,<sup>Δ</sup></p> <p>or cefuroxime,<sup>Δ</sup></p> <p>or ceftriaxone,</p> or cefotaxime ± metronidazole<sup>◊</sup></td> <td> <p>Ceftriaxone,</p> <p>or cefotaxime,</p> <p>or cefepime,</p> <p>or cefozopran,</p> or ceftazidime ± metronidazole<sup>◊</sup></td> <td rowspan="2"> <p>Cefepime,</p> <p>or ceftazidime,</p> or cefozopran ± metronidazole<sup>◊</sup></td> <td rowspan="2"> <p>Cefepime,</p> <p>or ceftazidime,</p> or cefozopran ± metronidazole<sup>◊</sup></td> </tr> <tr class="divider_bottom"> <td>Cefmetazole,<sup>Δ</sup> cefoxitin,<sup>Δ</sup> flomoxef,<sup>Δ</sup> cefoperazone/sulbactam</td> <td>Cefoperazone/sulbactam</td> </tr> <tr class="divider_bottom"> <td>Carbapenem-based therapy</td> <td>Ertapenem</td> <td>Ertapenem</td> <td>Imipenem/cilastatin, meropenem, doripenem, ertapenem</td> <td>Imipenem/cilastatin, meropenem, doripenem, ertapenem</td> </tr> <tr class="divider_bottom"> <td>Monobactam-based therapy</td> <td>–</td> <td>–</td> <td>Aztreonam ± metronidazole<sup>◊</sup></td> <td>Aztreonam ± metronidazole<sup>◊</sup></td> </tr> <tr> <td rowspan="2">Fluoroquinolone-based therapy<sup>§</sup></td> <td class="divider_bottom">Ciprofloxacin, levofloxacin, pazufloxacin ± metronidazole<sup>◊</sup></td> <td class="divider_bottom">Ciprofloxacin, levofloxacin, pazufloxacin ± metronidazole<sup>◊</sup></td> <td rowspan="2">–</td> <td rowspan="2">–</td> </tr> <tr> <td>Moxifloxacin</td> <td>Moxifloxacin</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>* Vancomycin is recommended to cover <em>Enterococcus</em> spp for grade III community-acquired acute cholangitis and cholecystitis and health-care-associated acute biliary infections. Linezolid or daptomycin is recommended if vancomycin-resistant <em>Enterococcus</em> (VRE) is known to be colonizing the patient, if previous treatment included vancomycin, and/or if the organism is common in the community.</p>
<p>¶ Ampicillin/sulbactam has little activity left against <em>Escherichia coli</em>. It has been removed from the North American guidelines<sup>[1,2]</sup>.</p>
<p>Δ Local antimicrobial susceptibility patterns (antibiogram) should be considered for use.</p>
<p>◊ Antianaerobic therapy, including use of metronidazole, tinidazole, or clindamycin, is warranted if a biliary-enteric anastomosis is present. The carbapenems, piperacillin/tazobactam, ampicillin/sulbactam, cefmetazole, cefoxitin, flomoxef, and cefoperazone/sulbactam have sufficient antianaerobic activity for this situation.</p>
§ Fluoroquinolone use is recommended if the susceptibility of cultured isolates is known or for patients with beta-lactam allergies. Many extended-spectrum beta-lactamase (ESBL)-producing gram-negative isolates are fluoroquinolone resistant.</div><div class="graphic_reference">References:
<ol>
<li>Mazuski JE, Tessier JM, May AK, et al. The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection. Surg Infect (Larchmt) 2017; 18:1.</li>
<li>Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:133.</li>
</ol>
<p class="extra_spacing_top">From: Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: Antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2018; 25(1):3-16. <a href="https://onlinelibrary.wiley.com/doi/abs/10.1002/jhbp.518" target="_blank">https://onlinelibrary.wiley.com/doi/abs/10.1002/jhbp.518</a>. Copyright © 2018 Japanese Society of Hepato-Biliary-Pancreatic Surgery. Reproduced with permission of John Wiley &amp; Sons Inc. This image has been provided by or is owned by Wiley. Further permission is needed before it can be downloaded to PowerPoint, printed, shared or emailed. Please contact Wiley's permissions department either via email: <a href="/cdn-cgi/l/email-protection#d6a6b3a4bbbfa5a5bfb9b8a596a1bfbab3aff8b5b9bb" target="_blank"><span class="__cf_email__" data-cfemail="e09085928d899393898f8e93a097898c8599ce838f8d">[email protected]</span></a> or use the RightsLink service by clicking on the 'Request Permission' link accompanying this article on Wiley Online Library (<a href="http://onlinelibrary.wiley.com" target="_blank">http://onlinelibrary.wiley.com</a>).</p></div><div id="graphicVersion">Graphic 117719 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
